# Corbus Pharmaceuticals Holdings, Inc.: Form 8-K, filed May 14, 2026

- Company: [Corbus Pharmaceuticals Holdings, Inc.](/companies/crbp.md) (CIK 1595097)
- Form: 8-K
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 08:15 ET
- Period: 2026-05-13
- Accession: 0001193125-26-222890
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1595097/000119312526222890/crbp-20260513.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1595097/000119312526222890/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1595097/000119312526222890/crbp-20260513.htm

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-222890. Last ingested by Listed: Nov 11, 2026, 02:00 ET. No prices; not investment advice.